IN2014MN01780A - - Google Patents
Download PDFInfo
- Publication number
- IN2014MN01780A IN2014MN01780A IN1780MUN2014A IN2014MN01780A IN 2014MN01780 A IN2014MN01780 A IN 2014MN01780A IN 1780MUN2014 A IN1780MUN2014 A IN 1780MUN2014A IN 2014MN01780 A IN2014MN01780 A IN 2014MN01780A
- Authority
- IN
- India
- Prior art keywords
- abx
- infection
- prescribed
- estimated
- antibiotics
- Prior art date
Links
- 229940079593 drug Drugs 0.000 abstract 3
- 239000003814 drug Substances 0.000 abstract 3
- 239000003242 anti bacterial agent Substances 0.000 abstract 2
- 229940088710 antibiotic agent Drugs 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 239000000090 biomarker Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000036541 health Effects 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000005180 public health Effects 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/44721—Arrangements for investigating the separated zones, e.g. localising zones by optical means
- G01N27/44726—Arrangements for investigating the separated zones, e.g. localising zones by optical means using specific dyes, markers or binding molecules
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/416—Systems
- G01N27/447—Systems using electrophoresis
- G01N27/44704—Details; Accessories
- G01N27/44717—Arrangements for investigating the separated zones, e.g. localising zones
- G01N27/44739—Collecting the separated zones, e.g. blotting to a membrane or punching of gel spots
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
- G01N33/6866—Interferon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153 or CD154
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Electrochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261596950P | 2012-02-09 | 2012-02-09 | |
| US201261652631P | 2012-05-29 | 2012-05-29 | |
| PCT/EP2013/052619 WO2013117746A1 (en) | 2012-02-09 | 2013-02-08 | Signatures and determinants for diagnosing infections and methods of use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014MN01780A true IN2014MN01780A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2015-07-03 |
Family
ID=47678877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1780MUN2014 IN2014MN01780A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 2012-02-09 | 2013-02-08 |
Country Status (12)
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8685898B2 (en) | 2009-01-15 | 2014-04-01 | Imdaptive, Inc. | Adaptive immunity profiling and methods for generation of monoclonal antibodies |
| CN103119444B (zh) | 2010-04-21 | 2016-10-26 | 米密德诊断学有限公司 | 区分细菌与病毒感染的标记物和决定因素以及其使用方法 |
| ES2679107T3 (es) | 2012-02-09 | 2018-08-22 | Memed Diagnostics Ltd. | Distintivos y determinantes para diagnosticar infecciones y métodos para usarlos |
| US10077478B2 (en) | 2012-03-05 | 2018-09-18 | Adaptive Biotechnologies Corp. | Determining paired immune receptor chains from frequency matched subunits |
| AU2013259544B9 (en) | 2012-05-08 | 2017-09-28 | Adaptive Biotechnologies Corporation | Compositions and method for measuring and calibrating amplification bias in multiplexed PCR reactions |
| US9708657B2 (en) | 2013-07-01 | 2017-07-18 | Adaptive Biotechnologies Corp. | Method for generating clonotype profiles using sequence tags |
| ES2741740T3 (es) | 2014-03-05 | 2020-02-12 | Adaptive Biotechnologies Corp | Métodos que usan moléculas sintéticas que contienen segmentos de nucleótidos aleatorios |
| US20150259729A1 (en) * | 2014-03-13 | 2015-09-17 | Opgen, Inc. | Methods of detecting multi-drug resistant organisms |
| US10066265B2 (en) | 2014-04-01 | 2018-09-04 | Adaptive Biotechnologies Corp. | Determining antigen-specific t-cells |
| US11390921B2 (en) | 2014-04-01 | 2022-07-19 | Adaptive Biotechnologies Corporation | Determining WT-1 specific T cells and WT-1 specific T cell receptors (TCRs) |
| ES2777529T3 (es) | 2014-04-17 | 2020-08-05 | Adaptive Biotechnologies Corp | Cuantificación de genomas de células inmunitarias adaptativas en una mezcla compleja de células |
| WO2015184017A1 (en) | 2014-05-27 | 2015-12-03 | Opgen, Inc. | Systems, apparatus, and methods for generating and analyzing resistome profiles |
| WO2015192050A1 (en) * | 2014-06-13 | 2015-12-17 | North Carolina State University | Aptamers with binding affinity to norovirus |
| RU2730836C2 (ru) | 2014-08-14 | 2020-08-26 | Мемед Диагностикс Лтд. | Вычислительный анализ биологических данных с применением многообразия и гиперплоскости |
| US20170234873A1 (en) | 2014-10-14 | 2017-08-17 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof |
| WO2016069886A1 (en) | 2014-10-29 | 2016-05-06 | Adaptive Biotechnologies Corporation | Highly-multiplexed simultaneous detection of nucleic acids encoding paired adaptive immune receptor heterodimers from many samples |
| US10246701B2 (en) | 2014-11-14 | 2019-04-02 | Adaptive Biotechnologies Corp. | Multiplexed digital quantitation of rearranged lymphoid receptors in a complex mixture |
| RU2758608C2 (ru) * | 2014-11-19 | 2021-11-01 | Конинклейке Филипс Н.В. | Способ диагностики с использованием hnl |
| CN111624345A (zh) * | 2014-12-11 | 2020-09-04 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| WO2016138122A1 (en) * | 2015-02-24 | 2016-09-01 | Adaptive Biotechnologies Corp. | Methods for diagnosing infectious disease and determining hla status using immune repertoire sequencing |
| WO2016161273A1 (en) | 2015-04-01 | 2016-10-06 | Adaptive Biotechnologies Corp. | Method of identifying human compatible t cell receptors specific for an antigenic target |
| EP3139171B1 (en) * | 2015-09-02 | 2020-02-12 | Labsystems Diagnostics Oy | Novel methods and kits for detecting of urea cycle disorders using mass spectrometry |
| DK3356558T3 (da) | 2015-09-30 | 2022-04-25 | Immunexpress Pty Ltd | Sirs patogenbiomarkører og anvendelser deraf |
| CN106918698B (zh) * | 2015-12-25 | 2019-11-22 | 广州瑞博奥生物科技有限公司 | 一种检测人受体酪氨酸激酶的磷酸化抗体芯片试剂盒 |
| US11466331B2 (en) | 2016-03-03 | 2022-10-11 | Memed Diagnostics Ltd. | RNA determinants for distinguishing between bacterial and viral infections |
| IL287757B (en) * | 2016-03-03 | 2022-07-01 | Memed Diagnostics Ltd | Analyzing rna for diagnosing infection type |
| CN106053831A (zh) * | 2016-06-05 | 2016-10-26 | 潘时辉 | 一种用于自身免疫病检测的试剂盒 |
| WO2017214061A1 (en) * | 2016-06-07 | 2017-12-14 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for diagnosis of bacterial and viral infections |
| US20200124593A1 (en) * | 2016-06-23 | 2020-04-23 | Memed Diagnostics Ltd. | Measuring trail by lateral flow immunoassay |
| CA3027341A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| EP4184167A1 (en) | 2016-07-10 | 2023-05-24 | MeMed Diagnostics Ltd. | Early diagnosis of infections |
| WO2018029690A1 (en) | 2016-08-10 | 2018-02-15 | Memed Diagnostics Ltd. | System and method for analysis of biological data |
| US10428325B1 (en) | 2016-09-21 | 2019-10-01 | Adaptive Biotechnologies Corporation | Identification of antigen-specific B cell receptors |
| EP3519834A4 (en) * | 2016-09-29 | 2020-06-17 | MeMed Diagnostics Ltd. | RISK ASSESSMENT AND DISEASE CLASSIFICATION METHODS |
| US11385241B2 (en) | 2016-09-29 | 2022-07-12 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| JP6903494B2 (ja) * | 2017-06-09 | 2021-07-14 | シスメックス株式会社 | 感染症を識別するための粒子分析方法 |
| US10209260B2 (en) | 2017-07-05 | 2019-02-19 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| EP3662285A4 (en) * | 2017-07-31 | 2021-04-28 | University Health Network | Biomarkers in ex vivo lung perfusion (evlp) perfusate |
| WO2019092703A1 (en) * | 2017-11-07 | 2019-05-16 | Memed Diagnostics Ltd. | Anti-trail antibodies and methods of use |
| CN111698937A (zh) * | 2017-11-28 | 2020-09-22 | 国立大学法人三重大学 | 检测方法 |
| US11254980B1 (en) | 2017-11-29 | 2022-02-22 | Adaptive Biotechnologies Corporation | Methods of profiling targeted polynucleotides while mitigating sequencing depth requirements |
| CN108039206B (zh) * | 2017-12-21 | 2021-11-09 | 北京大学深圳研究生院 | 一种传染病的诊治方法及系统 |
| WO2019147850A1 (en) * | 2018-01-27 | 2019-08-01 | Becton, Dickinson And Company | Multiplex lateral flow assay for differentiating bacterial infections from viral infections |
| US11484273B2 (en) * | 2018-03-06 | 2022-11-01 | International Business Machines Corporation | Determining functional age indices based upon sensor data |
| WO2019236768A1 (en) * | 2018-06-05 | 2019-12-12 | Washington University | Nasal genes used to identify, characterize, and diagnose viral respiratory infections |
| CN108486246B (zh) * | 2018-06-06 | 2020-06-09 | 青岛泱深生物医药有限公司 | 子痫前期的诊治标志物 |
| TWI819049B (zh) * | 2018-08-02 | 2023-10-21 | 香港商布萊特臨床研究有限公司 | 對正在運行中的臨床試驗進行動態數據監測和實時優化的系統，方法及實施過程 |
| EP3774841A1 (en) | 2018-08-27 | 2021-02-17 | Regeneron Pharmaceuticals, Inc. | Use of raman spectroscopy in downstream purification |
| US12331320B2 (en) | 2018-10-10 | 2025-06-17 | The Research Foundation For The State University Of New York | Genome edited cancer cell vaccines |
| US20210389329A1 (en) * | 2018-10-29 | 2021-12-16 | Thomas Jefferson University | Compositions and Methods for Discriminating Infectious from Non-Infectious CNS Disorders |
| CN112578125B (zh) * | 2019-09-27 | 2022-10-25 | 成都中医药大学 | 检测粪钙卫蛋白含量的试剂在制备卵巢病变筛查试剂盒中的用途 |
| CN110923333B (zh) * | 2019-12-11 | 2020-09-29 | 湖北省农业科学院畜牧兽医研究所 | 山羊zbp1基因第一内含子内与产羔数关联的单倍型标记及其应用 |
| WO2021117044A1 (en) | 2019-12-11 | 2021-06-17 | Ichilov Tech Ltd. | Non-invasive assay for differentiating between bacterial and viral infections |
| WO2021152595A1 (en) | 2020-01-29 | 2021-08-05 | Memed Diagnostics Ltd. | Methods of diagnosing and classifying viral infections |
| CA3170374A1 (en) | 2020-02-09 | 2021-08-12 | Nlc Pharma Ltd | Rapid detection test for sars-cov-2 |
| JP2023520813A (ja) | 2020-04-09 | 2023-05-19 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 気道感染症の診断のためのバイオマーカー |
| CN113533170A (zh) * | 2020-04-21 | 2021-10-22 | 贝克曼考尔特公司 | 病毒感染的血液学参数 |
| WO2022004730A1 (ja) * | 2020-06-30 | 2022-01-06 | 株式会社堀場製作所 | 体液分析装置、体液検体を判定するための方法、および、コンピュータープログラム |
| CN111816245B (zh) * | 2020-07-20 | 2022-09-09 | 成都博欣医学检验实验室有限公司 | 结合mNGS和临床知识库的病原微生物检测方法及系统 |
| WO2022153323A1 (en) * | 2021-01-18 | 2022-07-21 | Memed Diagnostics Ltd. | Markers for diagnosing infections |
| US20220298572A1 (en) * | 2021-03-16 | 2022-09-22 | Cepheid | Compositions and methods for discriminating bacterial and viral infections in a human subject |
| CN113945712A (zh) * | 2021-12-21 | 2022-01-18 | 山东中鸿特检生物科技有限公司 | 一种区别细菌、病毒感染的检测方法及检测试剂盒 |
| CN114441506B (zh) * | 2022-04-08 | 2022-06-21 | 港湾之星健康生物(深圳)有限公司 | 量子磁光传感器 |
| EP4357778A1 (en) | 2022-10-20 | 2024-04-24 | Heraeus Medical GmbH | Treatment of microbial infections diagnosed using the biomarker d-lactate |
Family Cites Families (144)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1178414A (en) | 1978-02-08 | 1984-11-27 | Toyo Boseki Kabushiki Kaisha (Trading Under The Name Of Toyobo Co., Ltd.) | Packaging material having excellent seal packaging property |
| US4233402A (en) | 1978-04-05 | 1980-11-11 | Syva Company | Reagents and method employing channeling |
| US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US4659678A (en) | 1982-09-29 | 1987-04-21 | Serono Diagnostics Limited | Immunoassay of antigens |
| US4727022A (en) | 1984-03-14 | 1988-02-23 | Syntex (U.S.A.) Inc. | Methods for modulating ligand-receptor interactions and their application |
| US5018067A (en) | 1987-01-12 | 1991-05-21 | Iameter Incorporated | Apparatus and method for improved estimation of health resource consumption through use of diagnostic and/or procedure grouping and severity of illness indicators |
| DE4322330A1 (de) | 1992-08-31 | 1994-03-03 | Behringwerke Ag | Verwendung des IL-4-Rezeptors zur Therapie, Prophylaxe und Diagnose von allergischen, viralen, parasitären und bakteriellen Erkrankungen sowie von Pilzinfektionen |
| DE4227454C1 (de) | 1992-08-19 | 1994-02-03 | Henning Berlin Gmbh | Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens |
| SE9401351D0 (sv) | 1994-04-21 | 1994-04-21 | Venge | A method for diagnosis |
| US5910421A (en) | 1995-12-21 | 1999-06-08 | University Of Florida | Rapid diagnostic method for distinguishing allergies and infections |
| US6077665A (en) | 1996-05-07 | 2000-06-20 | The Board Of Trustees Of The Leland Stanford Junior University | Rapid assay for infection in neonates |
| JP2002508933A (ja) | 1997-12-24 | 2002-03-26 | ダイアテック・ピーティワイ・リミテッド | 二官能分子 |
| CA2329868A1 (en) | 1998-05-18 | 1999-11-25 | Apoptosis Technology, Inc. | Compounds, screening methods, and uses involving anti-apoptotic genes and gene products |
| DE19847690A1 (de) | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
| US6709855B1 (en) | 1998-12-18 | 2004-03-23 | Scios, Inc. | Methods for detection and use of differentially expressed genes in disease states |
| AU1853600A (en) | 1999-01-06 | 2000-07-24 | Choong-Chin Liew | Method for the detection of gene transcripts in blood and uses thereof |
| ATE346914T1 (de) | 1999-08-24 | 2006-12-15 | Glycozym Aps | Udp-n-acetylglucosamin: galaktose-beta 1,3-n- acetylgalaktosamin-alpha-r/(glcnac -galnac) beta 1,6-n-acetylglucosaminyltransferase, c2gnt3 |
| IL132687A0 (en) | 1999-11-01 | 2001-03-19 | Keren Mechkarim Ichilov Pnimit | System and method for evaluating body fluid samples |
| US20020038227A1 (en) | 2000-02-25 | 2002-03-28 | Fey Christopher T. | Method for centralized health data management |
| US7668661B2 (en) | 2000-04-28 | 2010-02-23 | Siemens Healthcare Diagnostics Inc. | Liver disease-related methods and systems |
| AU2001273486A1 (en) | 2000-07-17 | 2002-01-30 | Labnetics, Inc. | Method and apparatus for the processing of remotely collected electronic information characterizing properties of biological entities |
| US20020055176A1 (en) | 2000-11-08 | 2002-05-09 | Ray Robert A. | Diagnostic assay system |
| CN1286985C (zh) | 2001-03-27 | 2006-11-29 | 株式会社东芝 | 与疾病相关的核酸 |
| US7713705B2 (en) | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
| DE10119804A1 (de) | 2001-04-23 | 2002-10-24 | Brahms Ag | Entzündungsspezifische Peptide und deren Verwendungen |
| CN100475848C (zh) | 2001-05-18 | 2009-04-08 | 麒麟麦酒株式会社 | 抗trail-r抗体 |
| FI115165B (fi) | 2001-06-04 | 2005-03-15 | Aboatech Ab Oy | Menetelmä infektion laadun määrittämiseksi |
| DE10130985B4 (de) | 2001-06-27 | 2004-03-18 | B.R.A.H.M.S Ag | Verfahren zur Diagnose von Sepsis und schweren Infektionen unter Bestimmung löslicher Cytokeratin-1-Fragmente |
| US20040209307A1 (en) * | 2001-08-20 | 2004-10-21 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
| DE50103907D1 (de) | 2001-12-07 | 2004-11-04 | Brahms Ag | Verwendungen der Aldose-1-Epimerase (Mutarotase) für die Diagnose von Entzündungserkrankungen und Sepsis |
| DE60207183T2 (de) | 2001-12-10 | 2006-08-10 | Kabushiki Gaisha K-And-S | Vorrichtung zur Beobachtung biologischer Daten |
| US20040038201A1 (en) | 2002-01-22 | 2004-02-26 | Whitehead Institute For Biomedical Research | Diagnostic and therapeutic applications for biomarkers of infection |
| US7468032B2 (en) | 2002-12-18 | 2008-12-23 | Cardiac Pacemakers, Inc. | Advanced patient management for identifying, displaying and assisting with correlating health-related data |
| US20040122296A1 (en) | 2002-12-18 | 2004-06-24 | John Hatlestad | Advanced patient management for triaging health-related data |
| JPWO2003081240A1 (ja) | 2002-03-22 | 2005-07-28 | 協和メデックス株式会社 | ウイルス感染症の判定方法 |
| US7485298B2 (en) * | 2002-05-23 | 2009-02-03 | Michael Powell | Diagnosis and treatment of human dormancy-related sequellae |
| KR20050040866A (ko) | 2002-06-11 | 2005-05-03 | 아이다호 리서치 파운데이션 | 바이러스 감염의 검출을 위한 ⅰ형 인터페론-유도성 단백질 |
| AU2003296921A1 (en) | 2002-10-31 | 2004-05-25 | Health Research, Inc. | Diagnostic test for west nile virus |
| US8563476B2 (en) | 2002-11-15 | 2013-10-22 | Morehouse School Of Medicine | Anti-CXCL9, anti-CXCL10, anti-CXCL11, anti-CXCL13, anti-CXCR3 and anti-CXCR5 agents for inflammatory disorders |
| AU2004245998A1 (en) | 2003-06-04 | 2004-12-16 | The Government of the United States as represented by The Secretary of the Department of Health and Human Services, Centres for Disease Control and Prevention | PNI microarray and uses |
| CA2537668A1 (en) | 2003-09-29 | 2005-04-14 | Biosite Incorporated | Methods and compositions for the diagnosis of sepsis |
| JP2005106694A (ja) | 2003-09-30 | 2005-04-21 | Mochida Pharmaceut Co Ltd | 敗血症早期検出及び重篤度評価 |
| GB0401730D0 (en) | 2004-01-27 | 2004-03-03 | Bioxell Spa | Diagnosis method |
| US8906630B2 (en) | 2004-02-27 | 2014-12-09 | The Trustees Of The University Of Pennsylvania | Assays for detecting pathogenic respiratory bacteria |
| US7892539B2 (en) * | 2004-03-24 | 2011-02-22 | The Regents Of The University Of California | Modulation of an innate immune response by altering TRIAL-R signaling |
| US8155993B2 (en) | 2004-06-15 | 2012-04-10 | Janssen Pharmaceutica, N.V. | Apparatus and methods for assessing a pharmaceutical product |
| CA2614507A1 (en) | 2004-07-09 | 2006-08-17 | Amaox, Ltd. | Immune cell biosensors and methods of using same |
| US7598080B2 (en) | 2004-08-20 | 2009-10-06 | Carl Deirmengian | Diagnostic assay for source of inflammation |
| EP1805500A4 (en) | 2004-09-28 | 2008-05-07 | Singulex Inc | SYSTEM AND METHOD FOR THE SPECTROSCOPIC ANALYSIS OF INDIVIDUAL PARTICLES |
| US7572640B2 (en) | 2004-09-28 | 2009-08-11 | Singulex, Inc. | Method for highly sensitive detection of single protein molecules labeled with fluorescent moieties |
| CN101218355A (zh) | 2004-11-05 | 2008-07-09 | 海军秘书处代表的美国政府 | 利用宿主血液生物基因表达标记诊断和预后判断感染性疾病的临床表型及其它生理状态 |
| WO2007018574A2 (en) | 2004-11-10 | 2007-02-15 | The United States Of America As Represented By The Secretary Of The Navy | Diagnostic assay for rickettsia prowazekii disease by detection of responsive gene expression |
| CN101208602A (zh) | 2005-04-15 | 2008-06-25 | 贝克顿迪金森公司 | 脓毒症的诊断 |
| US7767395B2 (en) | 2005-04-15 | 2010-08-03 | Becton, Dickinson And Company | Diagnosis of sepsis |
| US20070015172A1 (en) | 2005-06-01 | 2007-01-18 | Z-Biomed, Inc. | Expression profiles for microbial infection |
| UA78641C2 (en) | 2005-08-29 | 2007-04-10 | Open Joint Stock Company Conce | A process for the preparation of carbamide-formaldehyde resin |
| DE102005050933A1 (de) | 2005-10-21 | 2007-04-26 | Justus-Liebig-Universität Giessen | Erfindung betreffend Expressionsprofile zur Vorhersage von septischen Zuständen |
| CN101374964B (zh) | 2005-12-09 | 2013-07-17 | 贝勒研究院 | 外周血液白细胞转录模式的模块水平分析 |
| GB0601959D0 (en) | 2006-01-31 | 2006-03-15 | King S College London | Sepsis test |
| US20070184460A1 (en) | 2006-02-09 | 2007-08-09 | Wei-Mei Ching | Diagnostic assay for Orientia tsutsugamushi by detection of responsive gene expression |
| KR20090023360A (ko) | 2006-04-26 | 2009-03-04 | 버텍스 파마슈티칼스 인코포레이티드 | Ｃ형 간염 바이러스 감염 바이오마커 |
| SG177956A1 (en) | 2006-08-11 | 2012-02-28 | Baylor Res Inst | Gene expression signatures in blood leukocytes permit differential diagnosis of acute infections |
| WO2008028489A2 (en) | 2006-09-05 | 2008-03-13 | Hvidovre Hospital | Ip-i0 based immunological monitoring |
| AU2012244350B2 (en) | 2006-09-05 | 2013-08-15 | Statens Serum Institut | Ip-10 based immunological monitoring |
| WO2008041953A2 (en) | 2006-10-05 | 2008-04-10 | Agency For Science, Technology And Research | Dengue diagnosis and treatment |
| US20100143372A1 (en) | 2006-12-06 | 2010-06-10 | Medimmune, Llc | Interferon alpha-induced pharmacodynamic markers |
| DE102006060112A1 (de) | 2006-12-20 | 2008-06-26 | Brahms Aktiengesellschaft | Diagnose und Risikostratifizierung mittels dem neuen Marker CT-proADM |
| CN101617056A (zh) | 2006-12-21 | 2009-12-30 | 伊诺基因卡尔生物技术私人有限公司 | Eb病毒相关癌症的早期诊断方法及各自的试剂和试剂盒 |
| CN101622364A (zh) * | 2007-01-11 | 2010-01-06 | 杜克大学 | 监测hiv感染的方法 |
| US8293489B2 (en) | 2007-01-31 | 2012-10-23 | Henkin Robert I | Methods for detection of biological substances |
| BRPI0808150A2 (pt) | 2007-02-28 | 2014-07-01 | Procter & Gamble | Métodos e alvos para a identificação de compostos destinados a regular a infecção por rinovírus |
| DE102007009751A1 (de) * | 2007-02-28 | 2008-09-04 | B.R.A.H.M.S Aktiengesellschaft | Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens |
| EP2155909B1 (en) | 2007-06-01 | 2018-03-07 | Council Of Scientific & Industrial Research | Method for simultaneous detection and discrimination of bacterial, fungal, parasitic and viral infections of eye and central nervous system |
| RU2352948C1 (ru) | 2007-06-15 | 2009-04-20 | Государственное образовательное учреждение высшего профессионального образования "КРАСНОЯРСКАЯ ГОСУДАРСТВЕННАЯ МЕДИЦИНСКАЯ АКАДЕМИЯ ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ЗДРАВООХРАНЕНИЮ И СОЦИАЛЬНОМУ РАЗВИТИЮ" | Способ прогноза исхода заболевания пациентов с ургентной хирургической патологией органов брюшной полости |
| IL184478A (en) | 2007-07-08 | 2017-07-31 | Hadasit Medical Res Services & Development Ltd | Preparations, methods and kits for identifying carriers of mutations in genes 1brca and 2brca and for the early detection of cancers associated with mutations in these genes |
| DE102007035640A1 (de) | 2007-07-27 | 2009-01-29 | Lkh-Kunststoffwerk Gmbh & Co. Kg | Tauchkolben |
| ES2403310T3 (es) * | 2007-08-03 | 2013-05-17 | B.R.A.H.M.S Gmbh | Antibiótico para su utilización en una infección local |
| EP2020603A1 (en) | 2007-08-03 | 2009-02-04 | BRAHMS Aktiengesellschaft | Method for risk stratification in stable coronary artery disease |
| TW200920358A (en) | 2007-08-13 | 2009-05-16 | Lundbeck & Co As H | Method of treating stress-mediated depression |
| WO2009025743A2 (en) * | 2007-08-17 | 2009-02-26 | University Of Massachusetts Medical School | Use of trail compositions as antiviral agents |
| DE502007003414D1 (de) | 2007-09-24 | 2010-05-20 | Bmdsys Production Gmbh | Kryostat mit stabilisiertem Aussengefäss |
| EP2071334A1 (en) | 2007-12-14 | 2009-06-17 | Transmedi SA | Compositions and methods of detecting TIABS |
| WO2009100907A1 (en) | 2008-02-14 | 2009-08-20 | Dianeering Diagnostics Engineering And Research Gmbh | Means and methods for assessing the risk of patients presenting to emergency departments based on very low concentrations of troponin i or t or using a combination of markers |
| WO2009120800A2 (en) | 2008-03-25 | 2009-10-01 | University Of Southern California | Prognostic panel for urinary bladder cancer |
| RU2010146701A (ru) | 2008-04-21 | 2012-05-27 | Новартис Форшунгсстифтунг Цвайгнидерлассунг Фридрих Мишер Инститьют Фор Байомедикал Рисерч (Ch) | Противовирусная терапия |
| US9910036B2 (en) | 2008-05-20 | 2018-03-06 | Rapid Pathogen Screening, Inc. | Method and device for combined detection of viral and bacterial infections |
| EP2300829B1 (en) | 2008-05-23 | 2014-07-23 | Pronota NV | New biomarker for diagnosis, prediction and/or prognosis of sepsis and uses thereof |
| MX2010014556A (es) | 2008-06-25 | 2011-07-28 | Baylor Res Inst | Firma transcripcional de sangre por infeccion de mycobacterium tuberculosis. |
| CN102257386B (zh) | 2008-10-24 | 2014-12-31 | B.R.A.H.M.S有限公司 | 通过测定标志肽的水平在已患过中风或短暂性缺血性发作的患者中进行预后和风险评估 |
| JP2012508577A (ja) | 2008-11-12 | 2012-04-12 | カリス ライフ サイエンシズ ルクセンブルク ホールディングス | 表現型を決定するためのエキソソームの使用方法およびそのシステム |
| US20160041153A1 (en) | 2008-11-12 | 2016-02-11 | Kirk Brown | Biomarker compositions and markers |
| TW201021778A (en) | 2008-11-12 | 2010-06-16 | Alcon Res Ltd | Intraocular lens delivery device with a multi-part plunger tip |
| UA92843C2 (ru) | 2009-05-21 | 2010-12-10 | Институт Технической Теплофизики Национальной Академии Наук Украины | Способ получения порошкообразного пищевого красителя из столовой свеклы |
| WO2010138618A1 (en) | 2009-05-26 | 2010-12-02 | Duke University | Molecular predictors of fungal infection |
| JP5731489B2 (ja) | 2009-06-05 | 2015-06-10 | ベー．エル．アー．ハー．エム．エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 呼吸困難を起こした患者における細菌感染の検出 |
| EP2462438A4 (en) | 2009-08-07 | 2013-01-23 | Rules Based Medicine Inc | METHODS AND DEVICES FOR DETECTING REJECTION OF RENAL TRANSPLANT |
| JP5667353B2 (ja) | 2009-09-25 | 2015-02-12 | シスメックス株式会社 | 血球計数装置、診断支援装置、診断支援方法及びコンピュータプログラム |
| US8383332B2 (en) | 2009-10-13 | 2013-02-26 | B.R.A.H.M.S. Gmbh | Procalcitonin for the diagnosis of bacterial infections and guidance of antibiotic treatment in patients with acute stroke or transient ischemic attack |
| AU2010306593B2 (en) | 2009-10-15 | 2015-09-10 | Crescendo Bioscience, Inc. | Biomarkers and methods for measuring and monitoring inflammatory disease activity |
| AU2010328019A1 (en) | 2009-12-09 | 2012-06-28 | Aviir, Inc. | Biomarker assay for diagnosis and classification of cardiovascular disease |
| US20110312534A1 (en) | 2010-03-05 | 2011-12-22 | Erasmus University Medical Center Rotterdam | Method for prediction of human iris color |
| EP2365456B1 (en) | 2010-03-11 | 2016-07-20 | CompuGroup Medical SE | Data structure, method and system for predicting medical conditions |
| CN103119444B (zh) | 2010-04-21 | 2016-10-26 | 米密德诊断学有限公司 | 区分细菌与病毒感染的标记物和决定因素以及其使用方法 |
| CN103097891B (zh) | 2010-05-31 | 2015-09-09 | 国立大学法人德岛大学 | 疾病重症度的检查方法 |
| GB2482187A (en) | 2010-07-23 | 2012-01-25 | Univ Exeter | Predicting response to surgery |
| US8877212B2 (en) | 2011-02-07 | 2014-11-04 | Trudeau Institute | Use of an IL12 receptor-beta 1 splice variant to diagnose active tuberculosis |
| RU2476887C2 (ru) | 2011-03-29 | 2013-02-27 | Учреждение Российской академии медицинских наук Дальневосточный научный центр физиологии и патологии дыхания Сибирского отделения РАМН | Способ прогнозирования развития осложнений у больных внебольничной пневмонией |
| EP2722343A4 (en) | 2011-06-20 | 2014-12-17 | Kyowa Hakko Kirin Co Ltd | ANTI-ERBB3 ANTIBODIES |
| WO2013040062A2 (en) | 2011-09-12 | 2013-03-21 | Vanderbilt University | Characterizing multiple sclerosis |
| JP5842107B2 (ja) | 2011-10-19 | 2016-01-13 | パナソニックＩｐマネジメント株式会社 | 循環動態測定装置 |
| ES2656150T3 (es) | 2011-11-14 | 2018-02-23 | Universitätsklinikum Jena | Diagnóstico de la sepsis y del síndrome de respuesta inflamatoria sistémica |
| US10152702B2 (en) | 2012-02-07 | 2018-12-11 | Michael Ingber | Apparatus and methods for analyzing a medical condition |
| ES2679107T3 (es) | 2012-02-09 | 2018-08-22 | Memed Diagnostics Ltd. | Distintivos y determinantes para diagnosticar infecciones y métodos para usarlos |
| EP2637023A1 (en) | 2012-03-08 | 2013-09-11 | B.R.A.H.M.S GmbH | Prediction of outcome in patients with chronic obstructive pulmonary disease |
| EP2822602B1 (en) | 2012-03-08 | 2020-06-03 | Thommen Medical Ag | Chewing gum for the diagnosis of inflammatory tissues in dental applications |
| US9375493B2 (en) | 2012-03-30 | 2016-06-28 | Visen Medical, Inc. | Bacterial imaging agents and methods of using same |
| GB201211982D0 (en) | 2012-07-05 | 2012-08-22 | Isis Innovation | Biomarker |
| CN104769430B (zh) | 2012-07-10 | 2018-12-14 | 尼平蓝山地方医疗区 | 流感中的风险分层 |
| FR2996003B1 (fr) | 2012-09-25 | 2014-10-17 | Commissariat Energie Atomique | Methode pour detecter specifiquement dans un echantillon une metalloprotease matricielle (mmp) d'interet uniquement dans sa forme active |
| US20140127827A1 (en) | 2012-11-05 | 2014-05-08 | Gwangju Institute Of Science And Technology | Method for detection of antigen using fluorescence resonance energy transfer immunoassay |
| EP2926138A4 (en) | 2012-11-30 | 2016-09-14 | Applied Proteomics Inc | METHOD FOR DETERMINING THE STATE OF ACTIVITY BZW. THE RISK OF COLONCARCINOMES |
| MX360384B (es) | 2013-01-22 | 2018-10-31 | Imicroq S L | Metodo rapido para la deteccion de patogenos. |
| US20150363559A1 (en) | 2013-01-29 | 2015-12-17 | Molecular Health Gmbh | Systems and methods for clinical decision support |
| US10689701B2 (en) | 2013-03-15 | 2020-06-23 | Duke University | Biomarkers for the molecular classification of bacterial infection |
| US9474903B2 (en) | 2013-03-15 | 2016-10-25 | Boston Scientific Neuromodulation Corporation | Clinical response data mapping |
| WO2015042465A1 (en) | 2013-09-20 | 2015-03-26 | Astute Medical, Inc. | Methods and compositions for diagnosis and prognosis of appendicitis and differentiation of causes of abdominal pain |
| WO2015048098A1 (en) | 2013-09-24 | 2015-04-02 | Washington University | Diagnostic methods for infectious disease using endogenous gene expression |
| RU2730836C2 (ru) | 2014-08-14 | 2020-08-26 | Мемед Диагностикс Лтд. | Вычислительный анализ биологических данных с применением многообразия и гиперплоскости |
| US20170234873A1 (en) | 2014-10-14 | 2017-08-17 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections in non-human subjects and methods of use thereof |
| RU2758608C2 (ru) | 2014-11-19 | 2021-11-01 | Конинклейке Филипс Н.В. | Способ диагностики с использованием hnl |
| CN111624345A (zh) | 2014-12-11 | 2020-09-04 | 米密德诊断学有限公司 | 用于诊断多种感染的标记组合及其使用方法 |
| KR20160072626A (ko) | 2014-12-15 | 2016-06-23 | 전북대학교산학협력단 | 패혈증 인자 il-6 간이 진단 키트 |
| CA3003104A1 (en) | 2015-11-01 | 2017-05-04 | Elminda Ltd. | Method and system for estimating potential distribution on cortical surface |
| US11466331B2 (en) | 2016-03-03 | 2022-10-11 | Memed Diagnostics Ltd. | RNA determinants for distinguishing between bacterial and viral infections |
| IL287757B (en) | 2016-03-03 | 2022-07-01 | Memed Diagnostics Ltd | Analyzing rna for diagnosing infection type |
| US20200124593A1 (en) | 2016-06-23 | 2020-04-23 | Memed Diagnostics Ltd. | Measuring trail by lateral flow immunoassay |
| CA3027341A1 (en) | 2016-07-10 | 2018-01-18 | Memed Diagnostics Ltd. | Protein signatures for distinguishing between bacterial and viral infections |
| EP4184167A1 (en) | 2016-07-10 | 2023-05-24 | MeMed Diagnostics Ltd. | Early diagnosis of infections |
| JP7020689B2 (ja) | 2016-09-16 | 2022-02-16 | 株式会社オンチップ・バイオテクノロジーズ | 微粒子分注装置、微粒子解析装置、及び反応検出装置、並びにそれらを用いる方法 |
| EP3519834A4 (en) | 2016-09-29 | 2020-06-17 | MeMed Diagnostics Ltd. | RISK ASSESSMENT AND DISEASE CLASSIFICATION METHODS |
| US11385241B2 (en) | 2016-09-29 | 2022-07-12 | Memed Diagnostics Ltd. | Methods of prognosis and treatment |
| US10209260B2 (en) | 2017-07-05 | 2019-02-19 | Memed Diagnostics Ltd. | Signatures and determinants for diagnosing infections and methods of use thereof |
| US12348304B2 (en) | 2021-04-08 | 2025-07-01 | Infinidome Ltd. | Adjustable null steering in a stationary network |
-
2013
- 2013-02-08 ES ES13703112.6T patent/ES2679107T3/es active Active
- 2013-02-08 US US14/377,887 patent/US9726668B2/en active Active
- 2013-02-08 BR BR112014019733-4A patent/BR112014019733B1/pt active IP Right Grant
- 2013-02-08 CN CN201810781584.9A patent/CN108802385B/zh active Active
- 2013-02-08 EP EP13703112.6A patent/EP2812700B1/en active Active
- 2013-02-08 WO PCT/EP2013/052619 patent/WO2013117746A1/en active Application Filing
- 2013-02-08 EP EP18162713.4A patent/EP3367099B1/en active Active
- 2013-02-08 CA CA2863819A patent/CA2863819C/en active Active
- 2013-02-08 IN IN1780MUN2014 patent/IN2014MN01780A/en unknown
- 2013-02-08 CA CA3133249A patent/CA3133249C/en active Active
- 2013-02-08 AU AU2013217935A patent/AU2013217935B2/en active Active
- 2013-02-08 JP JP2014556086A patent/JP6169619B2/ja active Active
- 2013-02-08 EP EP21170448.1A patent/EP3882633A1/en not_active Withdrawn
- 2013-02-08 CN CN201380019055.0A patent/CN104204803B/zh active Active
- 2013-02-08 ES ES18162713T patent/ES2886979T3/es active Active
-
2014
- 2014-08-07 IL IL233998A patent/IL233998A/en active IP Right Grant
- 2014-08-15 ZA ZA2014/05993A patent/ZA201405993B/en unknown
-
2016
- 2016-08-16 US US15/237,728 patent/US10502739B2/en active Active
-
2017
- 2017-06-28 JP JP2017126712A patent/JP6725456B2/ja active Active
- 2017-08-22 IL IL254095A patent/IL254095B/en unknown
-
2018
- 2018-03-29 AU AU2018202302A patent/AU2018202302C1/en active Active
-
2019
- 2019-11-19 US US16/687,726 patent/US11175291B2/en active Active
-
2020
- 2020-06-25 JP JP2020109710A patent/JP2020180975A/ja active Pending
-
2021
- 2021-06-30 IL IL284506A patent/IL284506B/en unknown
- 2021-10-22 US US17/507,994 patent/US12188934B2/en active Active
-
2024
- 2024-12-24 US US19/000,814 patent/US20250189526A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014MN01780A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| MX2018004170A (es) | Biomarcadores relacionados con enfermedades mediadas por interleucina-33 (il-33) y usos de los mismos. | |
| EA201590655A8 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
| MX376691B (es) | Composición farmaceutica que comprende un antagonista de il-4r para tratar una infección cutánea. | |
| MX2016016800A (es) | Metodos para el tratamiento del sobrepeso o la obesidad. | |
| MX2021010672A (es) | Uso de un anticuerpo que tiene la capacidad para ligarse a clnd6 en el tratamiento o prevención de cáncer. | |
| EA201401028A1 (ru) | Фармацевтическая композиция, содержащая эмпаглифлозин и лекарственное средство от ожирения | |
| MX376652B (es) | Método para determinar la eficacia de una terapia con fármacos de direccionamiento a glipicano 3 (gpc3) contra cáncer. | |
| EA201691155A1 (ru) | Комбинации ингибиторов гистондеацетилазы и иммуномодулирующих лекарственных средств | |
| BR112014024159A2 (pt) | Formulações de vacina oral específicas do local gastrintestinal , ativas no íleo e apêndice. | |
| EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
| MX2013000674A (es) | Metodo para identificar a un paciente con incrementada probabilidad de responder a una terapia anticancer. | |
| MX2015005798A (es) | Terapia de combinacion. | |
| EA201391616A1 (ru) | Применение тиазолидных соединений для предотвращения и лечения вирусных заболеваний, рака и заболеваний, вызванных внутриклеточными инфекциями | |
| AR089862A1 (es) | USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA | |
| MX387627B (es) | Formación de imágenes de inflamación e infección dirigida a hsp90 y terapia | |
| WO2014015149A3 (en) | Use of microvesicles in diagnosis, prognosis, and treatment of medical diseases and conditions | |
| PH12015502500B1 (en) | Bacteriophage therapy | |
| MX2011013775A (es) | Un metodo para el tratamiento, alivio de sitomas de, mitigacion, mejoramieto y prevencion de una enfermedad, desorden o condicion cognoscitiva. | |
| EA201590460A1 (ru) | Способ и средство для лечения и профилактики заболеваний, вызываемых (+)рнк-содержащими вирусами | |
| MA39447A1 (fr) | (s)-pirlindole ou ses sels pharmaceutiquement acceptables pour une utilisation en médecine | |
| MX2013010367A (es) | Composiciones y metodos para la terapia y diagnostico de influenza. | |
| MA39448B1 (fr) | (r)-pirlindole et ses sels pharmaceutiquement acceptables destinés à un usage médical | |
| MX2019004200A (es) | Terapia de combinacion. | |
| EA202192767A1 (ru) | Способ лечения опосредуемой нонсенс-мутацией мышечной дистрофии дюшенна у педиатрических пациентов |